Brought to you by 
REVA Medical brings in $42mm through its latest round
13 May 2008
Executive Summary
REVA Medical (bioresorbable stents for arterial disease) has raised $42mm through the closing of its latest venture round. Cerberus Capital Management and Brookside Capital co-led the financing and were joined by Pequot Management and Medtronic as well as current backers Domain Partners and Group Outcome.
Deal Industry
- Biotechnology
- Medical Devices
-
Pharmaceuticals
-
Drug Delivery
- Site Specific
-
Drug Delivery
-
Medical Devices
- Biomaterials
- Implantable Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com